Episode 62
Biotech Hangout
00:00
Diesel Pharmaceuticals: A Good Opportunity to Raise Money
Diesel is a Chinese company. It was actually created is like a joint venture spinoff between AstraZeneca and like a private equity firm in China. There's a lot of companies developing drugs in this space. And, um, you know, Exxon 20 insertion mutations are very small patient population. So both, those, those are TANIB.
Transcript
Play full episode
